| # | Title | Journal | Year | Citations |
|---|
| 1 | Adipokines: The missing link between insulin resistance and obesity | Diabetes and Metabolism | 2008 | 598 |
| 2 | Inflammation and type 2 diabetes | Diabetes and Metabolism | 2012 | 363 |
| 3 | Role of the liver in the control of carbohydrate and lipid homeostasis | Diabetes and Metabolism | 2004 | 359 |
| 4 | Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease | Diabetes and Metabolism | 2003 | 355 |
| 5 | Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome | Diabetes and Metabolism | 2002 | 330 |
| 6 | Adipose tissue and adipokines: for better or worse | Diabetes and Metabolism | 2004 | 327 |
| 7 | What's in a risk factor? “He who strikes the ball” | Diabetes and Metabolism | 2003 | 321 |
| 8 | Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics | Diabetes and Metabolism | 2009 | 308 |
| 9 | European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary | Diabetes and Metabolism | 2011 | 266 |
| 10 | Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study | Diabetes and Metabolism | 2003 | 257 |
| 11 | The ins and outs of mitochondrial dysfunction in NASH | Diabetes and Metabolism | 2004 | 241 |
| 12 | Renin-angiotensin system inhibition prevents type 2 diabetes mellitus | Diabetes and Metabolism | 2004 | 238 |
| 13 | The role of the lipogenic pathway in the development of hepatic steatosis | Diabetes and Metabolism | 2008 | 234 |
| 14 | Diabetes mellitus and dementia | Diabetes and Metabolism | 2006 | 231 |
| 15 | Can we identify metabolically healthy but obese individuals (MHO)? | Diabetes and Metabolism | 2004 | 224 |
| 16 | Consequences of the diabetic status on the oxidant/antioxidant balance | Diabetes and Metabolism | 2000 | 223 |
| 17 | Medical follow up after bariatric surgery: nutritional and drug issues General recommendations for the prevention and treatment of nutritional deficiencies | Diabetes and Metabolism | 2009 | 220 |
| 18 | Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10) | Diabetes and Metabolism | 2020 | 220 |
| 19 | Metabolism of lipids in human white adipocyte | Diabetes and Metabolism | 2004 | 219 |
| 20 | Dietary patterns, inflammation and the metabolic syndrome | Diabetes and Metabolism | 2013 | 216 |
| 21 | The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study | Diabetes and Metabolism | 2003 | 214 |
| 22 | Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes | Diabetes and Metabolism | 2013 | 210 |
| 23 | Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease | Diabetes and Metabolism | 2018 | 210 |
| 24 | Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment | Diabetes and Metabolism | 2007 | 208 |
| 25 | Oxidative stress as a therapeutic target in diabetes: revisiting the controversy | Diabetes and Metabolism | 2003 | 204 |
| 26 | Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial | Diabetes and Metabolism | 2004 | 200 |
| 27 | Reducing insulin resistance with metformin: the evidence today | Diabetes and Metabolism | 2003 | 194 |
| 28 | The burden of type 2 diabetes: are we doing enough? | Diabetes and Metabolism | 2003 | 190 |
| 29 | Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies | Diabetes and Metabolism | 2008 | 188 |
| 30 | The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects | Diabetes and Metabolism | 1999 | 188 |
| 31 | Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome | Diabetes and Metabolism | 2005 | 187 |
| 32 | Fish oil prevents the adrenal activation elicited by mental stress in healthy men | Diabetes and Metabolism | 2003 | 179 |
| 33 | Adiponectin: An update | Diabetes and Metabolism | 2008 | 178 |
| 34 | Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss | Diabetes and Metabolism | 2000 | 178 |
| 35 | How can we measure insulin sensitivity/resistance? | Diabetes and Metabolism | 2011 | 176 |
| 36 | Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus | Diabetes and Metabolism | 2017 | 172 |
| 37 | Impact of gut microbiota on diabetes mellitus | Diabetes and Metabolism | 2016 | 169 |
| 38 | Chromium in the prevention and control of diabetes | Diabetes and Metabolism | 2000 | 166 |
| 39 | Adipose tissue and adipocyte dysregulation | Diabetes and Metabolism | 2014 | 161 |
| 40 | Insulin resistance: a contributing factor to age-related muscle mass loss? | Diabetes and Metabolism | 2005 | 160 |
| 41 | Advanced glycation end products, their receptors and diabetic angiopathy | Diabetes and Metabolism | 2001 | 158 |
| 42 | DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials | Diabetes and Metabolism | 2012 | 157 |
| 43 | Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders | Diabetes and Metabolism | 2007 | 156 |
| 44 | Renin-angiotensin system inhibition prevents type 2 diabetes mellitus | Diabetes and Metabolism | 2004 | 155 |
| 45 | Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgery | Diabetes and Metabolism | 2009 | 151 |
| 46 | New injection recommendations for patients with diabetes | Diabetes and Metabolism | 2010 | 151 |
| 47 | Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece | Diabetes and Metabolism | 2011 | 151 |
| 48 | Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes | Diabetes and Metabolism | 2005 | 149 |
| 49 | Abnormalities in insulin secretion in type 2 diabetes mellitus | Diabetes and Metabolism | 2008 | 148 |
| 50 | Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome | Diabetes and Metabolism | 2003 | 146 |
